Back

Sacubitril/Valsartan enhances skin wound healing through a sustained anti-inflammatory action; Implications for cardiac wound healing and cardiac reverse remodelling

17 May 2025 (15:24 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in basic science (1) Cardiac Biology and Physiology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Argyrios Ntalianis

Alexandra University Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Non-cell autonomous effects of Dnmt3a-mutant clonal haematopoiesis in ST-elevation myocardial infarction
Doctor M. Sadler (London, GB)
Abstract Slides Video
Presentation thumbnail
The role of left ventricular global longitudinal strain and myeloperoxidase in prognostication of major adverse clinical events for patients with ST elevation myocardial infarction and obesity
Doctor A. Kobets (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
Liver involvement in cardiovascular patients: role of perilipin-2 as a liver-specific biomarker, beyond cardiac damage
Doctor I. Fumarulo (Rome, IT)
Abstract Slides Video
Presentation thumbnail
The effect of S-glutathionylation on passive stiffness decreases with the maturation of sarcomeric structure
Miss B. Bodi (Debrecen, HU)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in basic science (1)

The Event

Event poster

Heart Failure 2025

17 May 2025 15:24 CET
You may be interested in
thumbnail
Congress Presentation
The positive effect of sacubitril/valsartan therapy on QRS width and QTC interval on electrocardiogram in heart failure patients with reduced ejection fraction
thumbnail
Congress Presentation
Sacubitril/valsartan compared to valsartan in regressing myocardial fibrosis in stage B heart failure: the REVERSE-LVH Trial
thumbnail
Congress Presentation
Comparing the anti-remodeling effect of sacubitril/valsartan and angiotensin-converting enzyme inhibition on myocardial samples of advanced heart failure patients undergoing heart transplantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources